1 Nov
2020

Deutsche Telekom patent auction; Exclusive IBM IP head interview; UMC’s huge trade secrets fine; Tough times for China’s attorneys; Bayer’s $4bn IP deal; plus much more

Everything we covered on IAM over the last seven days – and all you need to know from the global IP market to set yourself up for the start of another busy week

MONDAY 26th October

Requirements to practise patents have long complicated IP strategies in India and Indonesia, but there have been positive developments for rightsholders in both countries. Read more here

A recent court of appeal decision in France is bad news for pharma IP owners, but makes the country a potentially more attractive venue for SPC nullity actions. Read more here

“Patent sales are now an integral part of our innovation cycle,” says IBM IP head William LaFontaine in an exclusive IAM interview. Read more here

TUESDAY 27th October

Two recent patent and business deals in Asia involving DuPont suggest the chemicals giant is looking to monetise its IP portfolio around core chipmaking technologies. Read more here

Health insurer’s damages win against AstraZeneca in the Netherlands creates additional patent risk for life sciences companies. Read more here

Major patent-owning businesses, industry organisations and individual inventors have written to Congressional leaders in support of PTAB reforms introduced by USPTO Director Andrei Iancu. Read more here

WEDNESDAY 28th October

Clarivate's acquisition of Chinese patent data provider IncoPat is a hugely significant move in a market that generates more IP information than any other. Read more here

The IAM Strategy 300 identifies those whose IP knowledge and expertise create significant added value for their companies and clients. We are now inviting nominations for next year's edition. Read more here

As LOT Network hits member 1,000 and new research reveals that its membership owns over 12% of active US patents, CEO Ken Seddon talks exclusively with IAM about the defensive player's future. Read more here

THURSDAY 29th October

Taiwanese company UMC will be fined $60 million for its role in the acquisition of confidential Micron IP - the second-largest penalty ever imposed in a US criminal trade secrets case. Read more here

Bayer’s $4 billion AskBio buyout highlights new transaction patterns around cutting-edge biotech IP and suggests industry M&A is continuing to recover. Read more here

In early December, Deutsche Telekom is holding an online auction to sell off 168 patent assets across 21 families covering smart traffic and real-time navigation technology. Read more here

FRIDAY 30th October

Senior Chinese patent attorneys say their profession was once seen as a licence to print money, but fees for the services they provide and incomes for practitioners have stagnated. Read more here

Despite a growing amount of data, there are still significant holes to plug before a clear picture of patent litigation risk for foreign companies emerges in China. Read more here

Nokia secures second injunction win against Daimler in Germany, while details emerge of a “major” patent licence renewal for the Finnish telco. Read more here

SATURDAY 31st October

The growing influence of high-tech in the life sciences industry has led to speculation that the IP strategies used in both sectors will converge - but that is unlikely to happen. Read more here

Joff Wild

Author | Editor-in-chief

[email protected]

Joff Wild